As of 2024-12-14, the Relative Valuation of Travere Therapeutics Inc (TVTX) is (75.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.32 USD, the upside of Travere Therapeutics Inc based on Relative Valuation is -534.4%.
The range of the Relative Valuation is (77.33) - (113.00) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.0x - 27.6x | 17.3x |
| Forward P/E multiples | 18.9x - 30.8x | 19.4x |
| Fair Price | (77.33) - (113.00) | (75.24) |
| Upside | -546.5% - -752.4% | -534.4% |
| Date | P/E |
| 2024-12-13 | -4.38 |
| 2024-12-12 | -4.37 |
| 2024-12-11 | -4.56 |
| 2024-12-10 | -4.57 |
| 2024-12-09 | -4.58 |
| 2024-12-06 | -4.69 |
| 2024-12-05 | -4.73 |
| 2024-12-04 | -4.72 |
| 2024-12-03 | -4.73 |
| 2024-12-02 | -4.77 |
| 2024-11-29 | -4.59 |
| 2024-11-27 | -4.56 |
| 2024-11-26 | -4.65 |
| 2024-11-25 | -4.43 |
| 2024-11-22 | -4.45 |
| 2024-11-21 | -4.45 |
| 2024-11-20 | -4.36 |
| 2024-11-19 | -4.24 |
| 2024-11-18 | -4.24 |
| 2024-11-15 | -4.32 |
| 2024-11-14 | -4.50 |
| 2024-11-13 | -4.53 |
| 2024-11-12 | -4.57 |
| 2024-11-11 | -4.64 |
| 2024-11-08 | -4.84 |
| 2024-11-07 | -4.31 |
| 2024-11-06 | -4.22 |
| 2024-11-05 | -4.33 |
| 2024-11-04 | -4.41 |
| 2024-11-01 | -4.29 |
| 2024-10-31 | -4.27 |
| 2024-10-30 | -4.33 |
| 2024-10-29 | -4.48 |
| 2024-10-28 | -4.36 |
| 2024-10-25 | -4.28 |
| 2024-10-24 | -4.41 |
| 2024-10-23 | -4.38 |
| 2024-10-22 | -4.38 |
| 2024-10-21 | -4.41 |
| 2024-10-18 | -4.36 |
| 2024-10-17 | -4.45 |
| 2024-10-16 | -4.40 |
| 2024-10-15 | -4.31 |
| 2024-10-14 | -4.25 |
| 2024-10-11 | -4.00 |
| 2024-10-10 | -4.17 |
| 2024-10-09 | -4.29 |
| 2024-10-08 | -3.71 |
| 2024-10-07 | -3.72 |
| 2024-10-04 | -3.71 |